Post-pandemic Era-Global Active Pharmaceutical Ingredients (API) Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

Report ID: 247667 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Active Pharmaceutical Ingredients (API) Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 CNS -Product Introduction and Major Manufacturers
      1.1.2 Cardiovascular -Product Introduction and Major Manufacturers
      1.1.3 Genitourinary/Hormonal Drugs -Product Introduction and Major Manufacturers
      1.1.4 Respiratory -Product Introduction and Major Manufacturers
      1.1.5 Rheumatology -Product Introduction and Major Manufacturers
      1.1.6 Diabetes -Product Introduction and Major Manufacturers
      1.1.7 Oncology -Product Introduction and Major Manufacturers
      1.1.8 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Active Pharmaceutical Ingredients (API) Market Assessment, by Segmentation
    2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
    2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
    2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
    3.1 China Active Pharmaceutical Ingredients (API) Market
      3.1.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in China (2015-2020)
      3.1.2 Sales Value of Major Company in China Market (2015-2020)
      3.1.3 China Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
      3.1.4 Sales in China Market, by Type (2015-2026)
    3.2 EU Active Pharmaceutical Ingredients (API) Market
      3.2.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in EU (2015-2020)
      3.2.2 Sales Value of Major Company in EU Market (2015-2020)
      3.2.3 EU Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
      3.2.4 Sales in EU Market, by Type (2015-2026)
    3.3 USA Active Pharmaceutical Ingredients (API) Market
      3.3.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in USA (2015-2020)
      3.3.2 Sales Value of Major Company in USA Market (2015-2020)
      3.3.3 USA Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
      3.3.4 Sales in USA Market, by Type (2015-2026)
    3.4 Japan Active Pharmaceutical Ingredients (API) Market
      3.4.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in Japan (2015-2020)
      3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
      3.4.3 Japan Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
      3.4.4 Sales in Japan Market, by Type (2015-2026)
    3.5 India Active Pharmaceutical Ingredients (API) Market
      3.5.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in India (2015-2020)
      3.5.2 Sales Value of Major Company in India Market (2015-2020)
      3.5.3 India Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
      3.5.4 Sales in India Market, by Type (2015-2026)
    3.6 Southeast Asia Active Pharmaceutical Ingredients (API) Market
      3.6.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in Southeast Asia (2015-2020)
      3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
      3.6.3 Southeast Asia Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
      3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
    3.7 South America Active Pharmaceutical Ingredients (API) Market
      3.7.1 Top Companies leading Active Pharmaceutical Ingredients (API) Development in South America (2015-2020)
      3.7.2 Sales Value of Major Company in South America Market (2015-2020)
      3.7.3 South America Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
      3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
    4.1 Active Pharmaceutical Ingredients (API) Value Chain Analysis
      4.1.1 Upstream
      4.1.2 Downstream
    4.2 COVID-19 Impact on Active Pharmaceutical Ingredients (API) Industry
      4.2.1 Industrial Policy Issued Under the Epidemic Situation
    4.3 Cost-Under the Epidemic Situation
      4.3.1 Cost of Raw Material
    4.4 Channel Analysis
      4.4.1 Distribution Channel-Under the Epidemic Situation
      4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
    5.1 Global Active Pharmaceutical Ingredients (API) Sales and Growth Rate (2021-2026)
    5.2 Global Active Pharmaceutical Ingredients (API) Sales Value and Growth Rate (2021-2026)

6 Active Pharmaceutical Ingredients (API) Competitive Analysis
     6.1 SGS South Africa
        6.1.1 SGS South Africa Company Profiles
        6.1.2 SGS South Africa Product Introduction
        6.1.3 SGS South Africa Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        6.1.4 SWOT Analysis
     6.2 Ketlaphela Pharmaceutical
        6.2.1 Ketlaphela Pharmaceutical Company Profiles
        6.2.2 Ketlaphela Pharmaceutical Product Introduction
        6.2.3 Ketlaphela Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        6.2.4 SWOT Analysis
     6.3 Yokogawa South Africa
        6.3.1 Yokogawa South Africa Company Profiles
        6.3.2 Yokogawa South Africa Product Introduction
        6.3.3 Yokogawa South Africa Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        6.3.4 SWOT Analysis
     6.4 Aurobindo pharma
        6.4.1 Aurobindo pharma Company Profiles
        6.4.2 Aurobindo pharma Product Introduction
        6.4.3 Aurobindo pharma Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        6.4.4 SWOT Analysis
     6.5 Cipla
        6.5.1 Cipla Company Profiles
        6.5.2 Cipla Product Introduction
        6.5.3 Cipla Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        6.5.4 SWOT Analysis
     6.6 Haerbin Pharmaceutical
        6.6.1 Haerbin Pharmaceutical Company Profiles
        6.6.2 Haerbin Pharmaceutical Product Introduction
        6.6.3 Haerbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        6.6.4 SWOT Analysis
     6.7 Lupin
        6.7.1 Lupin Company Profiles
        6.7.2 Lupin Product Introduction
        6.7.3 Lupin Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        6.7.4 SWOT Analysis
     6.8 Bachem
        6.8.1 Bachem Company Profiles
        6.8.2 Bachem Product Introduction
        6.8.3 Bachem Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        6.8.4 SWOT Analysis
7 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Active Pharmaceutical Ingredients (API) Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Active Pharmaceutical Ingredients (API) Sales (K Unit) by Type (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Market Share (%) by Type (2019 -2020)
    Table Global Active Pharmaceutical Ingredients (API) Sales Value (Million USD) by Type (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Value Market Share (%) by Type (2019-2020)
    Table Global Active Pharmaceutical Ingredients (API) Sales (K Unit) by Application (2015-2026)
    Table China Active Pharmaceutical Ingredients (API) Sales (K Unit) of Major Company (2015-2020)
    Table China Active Pharmaceutical Ingredients (API) Sales Market Share of Major Company (2015-2020)
    Table China Active Pharmaceutical Ingredients (API) Sales Value (Million USD) of Major Company (2015-2020)
    Figure China Active Pharmaceutical Ingredients (API) Sales Value (Million USD) and Growth Rate (2015-2020)
    Table China Active Pharmaceutical Ingredients (API) Sales Value Share of Major Company (2015-2020)
    Table China Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
    Table China Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Figure China Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Table EU Active Pharmaceutical Ingredients (API) Sales (K Unit) of Major Company (2015-2020)
    Table EU Active Pharmaceutical Ingredients (API) Sales Market Share of Major Company (2015-2020)
    Table EU Active Pharmaceutical Ingredients (API) Sales Value (Million USD) of Major Company (2015-2020)
    Figure EU Active Pharmaceutical Ingredients (API) Sales Value (Million USD) and Growth Rate (2015-2020)
    Table EU Active Pharmaceutical Ingredients (API) Sales Value Share of Major Company (2015-2020)
    Table EU Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
    Table EU Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Figure EU Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Table USA Active Pharmaceutical Ingredients (API) Sales (K Unit) of Major Company (2015-2020)
    Table USA Active Pharmaceutical Ingredients (API) Sales Market Share of Major Company (2015-2020)
    Table USA Active Pharmaceutical Ingredients (API) Sales Value (Million USD) of Major Company (2015-2020)
    Figure USA Active Pharmaceutical Ingredients (API) Sales Value (Million USD) and Growth Rate (2015-2020)
    Table USA Active Pharmaceutical Ingredients (API) Sales Value Share of Major Company (2015-2020)
    Table USA Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
    Table USA Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Figure USA Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Table Japan Active Pharmaceutical Ingredients (API) Sales (K Unit) of Major Company (2015-2020)
    Table Japan Active Pharmaceutical Ingredients (API) Sales Market Share of Major Company (2015-2020)
    Table Japan Active Pharmaceutical Ingredients (API) Sales Value (Million USD) of Major Company (2015-2020)
    Figure Japan Active Pharmaceutical Ingredients (API) Sales Value (Million USD) and Growth Rate (2015-2020)
    Table Japan Active Pharmaceutical Ingredients (API) Sales Value Share of Major Company (2015-2020)
    Table Japan Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
    Table Japan Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Figure Japan Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Table India Active Pharmaceutical Ingredients (API) Sales (K Unit) of Major Company (2015-2020)
    Table India Active Pharmaceutical Ingredients (API) Sales Market Share of Major Company (2015-2020)
    Table India Active Pharmaceutical Ingredients (API) Sales Value (Million USD) of Major Company (2015-2020)
    Figure India Active Pharmaceutical Ingredients (API) Sales Value (Million USD) and Growth Rate (2015-2020)
    Table India Active Pharmaceutical Ingredients (API) Sales Value Share of Major Company (2015-2020)
    Table India Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
    Table India Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Figure India Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Table Southeast Asia Active Pharmaceutical Ingredients (API) Sales (K Unit) of Major Company (2015-2020)
    Table Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share of Major Company (2015-2020)
    Table Southeast Asia Active Pharmaceutical Ingredients (API) Sales Value (Million USD) of Major Company (2015-2020)
    Figure Southeast Asia Active Pharmaceutical Ingredients (API) Sales Value (Million USD) and Growth Rate (2015-2020)
    Table Southeast Asia Active Pharmaceutical Ingredients (API) Sales Value Share of Major Company (2015-2020)
    Table Southeast Asia Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
    Table Southeast Asia Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Figure Southeast Asia Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Table South America Active Pharmaceutical Ingredients (API) Sales (K Unit) of Major Company (2015-2020)
    Table South America Active Pharmaceutical Ingredients (API) Sales Market Share of Major Company (2015-2020)
    Table South America Active Pharmaceutical Ingredients (API) Sales Value (Million USD) of Major Company (2015-2020)
    Figure South America Active Pharmaceutical Ingredients (API) Sales Value (Million USD) and Growth Rate (2015-2020)
    Table South America Active Pharmaceutical Ingredients (API) Sales Value Share of Major Company (2015-2020)
    Table South America Active Pharmaceutical Ingredients (API) Price (USD/Unit), by Type (2019-2020)
    Table South America Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Figure South America Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Figure Value Chain Structure of Active Pharmaceutical Ingredients (API)
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Active Pharmaceutical Ingredients (API)
    Figure Cost Structure of Active Pharmaceutical Ingredients (API) in 2020
    Table Distributors/Traders List
    Table Regional Market Sales (K Unit) (2021-2026)
    Table Regional Market Sales Share (2021-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales (Unit), Growth Rate & Market Share (2021-2026)
    Table Regional Market Sales Value (Million USD) (2021-2026)
    Table Regional Market Sales Value Share (2021-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table SGS South Africa Profiles
    Table SGS South Africa Active Pharmaceutical Ingredients (API) Product Introduction
    Table SGS South Africa Active Pharmaceutical Ingredients (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure SGS South Africa SWOT Analysis
    Table Ketlaphela Pharmaceutical Profiles
    Table Ketlaphela Pharmaceutical Active Pharmaceutical Ingredients (API) Product Introduction
    Table Ketlaphela Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Ketlaphela Pharmaceutical SWOT Analysis
    Table Yokogawa South Africa Profiles
    Table Yokogawa South Africa Active Pharmaceutical Ingredients (API) Product Introduction
    Table Yokogawa South Africa Active Pharmaceutical Ingredients (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Yokogawa South Africa SWOT Analysis
    Table Aurobindo pharma Profiles
    Table Aurobindo pharma Active Pharmaceutical Ingredients (API) Product Introduction
    Table Aurobindo pharma Active Pharmaceutical Ingredients (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Aurobindo pharma SWOT Analysis
    Table Cipla Profiles
    Table Cipla Active Pharmaceutical Ingredients (API) Product Introduction
    Table Cipla Active Pharmaceutical Ingredients (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Cipla SWOT Analysis
    Table Haerbin Pharmaceutical Profiles
    Table Haerbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Introduction
    Table Haerbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Haerbin Pharmaceutical SWOT Analysis
    Table Lupin Profiles
    Table Lupin Active Pharmaceutical Ingredients (API) Product Introduction
    Table Lupin Active Pharmaceutical Ingredients (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Lupin SWOT Analysis
    Table Bachem Profiles
    Table Bachem Active Pharmaceutical Ingredients (API) Product Introduction
    Table Bachem Active Pharmaceutical Ingredients (API) Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Active Pharmaceutical Ingredients Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Active Pharmaceutical Ingredients Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Active Pharmaceutical Ingredients Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports